Relativity Acquisition Corp. Announces the Public Filing of a Registration Statement on Form F-4 for Instinct Bio Technical Company Inc.

Las Vegas, NV, Tokyo, Japan, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Relativity Acquisition Corp. (“Relativity”) today announced that on September 8, 2025, Instinct Bio Technical Company Inc. (“Instinct Bio”) publicly filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form F-4 (the “Form F-4”) in connection with Relativity’s previously announced proposed business combination (the “Business Combination”) with Instinct Brothers Co., Ltd. (“Instinct Brothers”), a vertically integrated stem cell skincare and wellness  company headquartered in Tokyo, Japan. The Form F-4, which includes a preliminary proxy statement/prospectus, provides detailed information regarding the proposed Business Combination and the related shareholder vote, and is available on the SEC’s website at www.sec.gov. Upon closing the Business Combination, the combined company will operate under the name Instinct Bio Technical Company Holdings Inc.  and intends to list on the NASDAQ Stock Exchange under the ticker symbol ‘BIOT’.